Hepatitis C virus infection trends in italy, 1996-2006

Hepatitis Monthly

Volumn 11, Issue 11, 2011, Pages 895-900

  la Torre, Giuseppe ^a   Gualano, Maria Rosaria ^b   Semyonov, Leda ^a   Nicolotti, Nicola ^b   Ricciardi, Walter ^b   Boccia, Antonio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Hepatitis C; Infection; Italy; Trend

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; NULL HYPOTHESIS; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SOCIAL CHANGE;

EID: 82955229520     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.767     Document Type: Article

References (45)

1. Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002;36(5 Suppl 1):S30-4.
2. Yenen S. Hepatitis C virus. In: Willke TA, Soyletir G, Doanay M, editors. Infectious Disease. Istanbul: Nobel Medical; 1996. p. 700-04.
3. Init iative for Vaccine Research, World Health Organization. State of the art of vaccine research and development. WHO. [updated 2005 January]; Available from: http://www.who.int/vaccine_research/documents/Dip%20814.pdf.
4. Wasley A, Miller JT, Finelli L. Surveillance for acute viral hepatitis- -United States, 2005. MMWR Surveill Summ. 2007;56(3):1-24.
5. Tibbs CJ. Methods of transmission of hepatitis C. J Viral Hepat. 1995;2(3):113-9.
6. La Torre G, Miele L, Mannocci A, Chiaradia G, Berloco F, Gabrieli ML, et al. Correlates of HCV seropositivity among familial contacts of HCV positive patients. BMC Public Health. 2006;6:237.
7. Honda M, Kaneko S, Unoura M, Kobayashi K, Murakami S. Risk of hepatitis C virus infections through household contact with chronic carriers: analysis of nucleotide sequences. Hepatology. 1993;17(6):971-6.
8. Akahane Y, Kojima M, Sugai Y, Sakamoto M, Miyazaki Y, Tanaka T, et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med. 1994;120(9):748-52.
9. Brusaferro S, Barbone F, Andrian P, Brianti G, Ciccone L, Furlan A, et al. A study on the role of the family and other risk factors in HCV transmission. Eur J Epidemiol. 1999;15(2):125-32.
10. Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat. 2007;14(2):107-15.
11. Mariano A, Scalia Tomba G, Tosti ME, Spada E, Mele A. Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy. Scand J Infect Dis. 2009;41(9):689-99.
12. Mele A, Rosmini F, Zampieri A, Gill ON. Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol. 1986;2(4):300-4.
13. Hea lth for All Database. Italian National Institute of Statistics. ISTAT. [updated 2011]; Available from: http://en.istat.it/.
14. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-51.
15. Hep atitis C--global prevalence (update). Wkly Epidemiol Rec. 1999;74(49):425-7.
16. Wor ld Health Organization. Hepatitis C. Fact sheet N°164. WHO. [updated 2011 June]; Available from: http://www.who.int/mediacentre/factsheets/fs164/en/index.html.
17. de Waure C, Cefalo C, Chiaradia G, Sferrazza A, Miele L, Gasbarrini G, et al. Intrafamilial transmission of hepatitis C virus in Italy: a systematic review. J Epidemiol Community Health. 2010;64(10):843-8.
18. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: Changing the epidemiology. Hemodial Int. 2008;12(3):378-82.
19. Campello C, Poli A, Dal MG, Besozzi-Valentini F. Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community- based population study in northern Italy. Infection. 2002;30(1):7-12.
20. Catalani C, Biggeri A, Gottard A, Benvenuti M, Frati E, Cecchini C. Prevalence of HCV infection among health care workers in a hospital in central Italy. Eur J Epidemiol. 2004;19(1):73-7.
21. Floridia M, Tamburrini E, Anzidei G, Tibaldi C, Muggiasca ML, Guaraldi G, et al. Declining HCV seroprevalence in pregnant women with HIV. Epidemiol Infect. 2010;138(9):1317-21.
22. Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis. 2011;11:88.
23. Girardi E, Zaccarelli M, Tossini G, Puro V, Narciso P, Visco G. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis. 1990;22(6):751-2.
24. Jain A, Rana SS, Chakravarty P, Gupta RK, Murthy NS, Nath MC, et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol. 2003;18(7):695-7.
25. Koulentaki M, Spanoudakis S, Kantidaki E, Drandakis P, Tzagarakis N, Biziagos E, et al. Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study. J Viral Hepat. 1999;6(3):243-8.
26. Mart in Sanchez V, Lopez Caleya JF, Nunez Vasquez MG, Moris Gonzalez ML, Perez Vicente R, Cayla Buqueras JA. [HCV and HIV infection, and coinfection in the Leon health area in the period 1993-2004]. Rev Esp Salud Publica. 2009;83(4):533-41.
27. Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis. 2008;8:43.
28. Offergeld R, Faensen D, Ritter S, Hamouda O. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro surveillance. 2005;10(2):8-11.
29. Oliveira ML, Yoshida CF, Telles PR, Hacker MA, Oliveira SA, Miguel JC, et al. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Epidemiol Infect. 2009;137(7):970-9.
30. Osella AR, Misciagna G, Leone A, Di Leo A, Fiore G. Epidemiology of hepatitis C virus infection in an area of Southern Italy. J Hepatol. 1997;27(1):30-5.
31. Raffaele A, Valenti M, Iovenitti M, Matani A, Bruno ML, Altobelli E, et al. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol. 2001;17(1):41-6.
32. Sweeting MJ, Hope VD, Hickman M, Parry JV, Ncube F, Ramsay ME, et al. Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again? Am J epidemiol. 2009;170(3):352.
33. Tseng FC, O'Brien TR, Zhang M, Kral AH, Ortiz-Conde BA, Lorvick J, et al. Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology. 2007;46(3):666-71.
34. van den Berg CH, Smit C, Bakker M, Geskus RB, Berkhout B, Jurriaans S, et al. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur J Epidemiol. 2007;22(3):183-93.
35. Garcia-Fulgueiras A, Tormo MJ, Rodriguez T, Perez-Flores D, Chirlaque D, Navarro C. Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2,203 adults. Scand J Infect Dis. 1996;28(1):17-20.
36. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003;18(6):551-7.
37. Goritsas C, Plerou I, Agaliotis S, Spinthaki R, Mimidis K, Velissaris D, et al. HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology. 2000;47(33):782-5.
38. Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL. Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology. 2005;42(6):1406-13.
39. Memish ZA, Knawy BA, El-Saed A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis. 2010;14(2):e115-20.
40. Naoumov NV. Hepatitis C virus infection in Eastern Europe. J Hepatol. 1999;31(Suppl 1):84-7.
41. Nkengasong JN, De Beenhouwer H, Claeys H, Nyambi P, Ayuk J, van der Groen G, et al. A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Cameroon. Am J Trop Med Hyg. 1995;52(1):98-100.
42. Znyk M. [Hepatitis C in lodzkie voivodeship in 2003-2008]. Przegl Epidemiol. 2010;64(3):367-72.
43. Spada E, Mele A, Ciccozzi M, Tosti ME, Bianco E, Szklo A, et al. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis. 2001;33(9):778-84.
44. Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol. 2008;42(5):527-32.
45. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47(RR- 19):1-39.